What is the history of Peyronies Disease?

Peyronie’s disease was first formally described by French physician François Gigot de la Peyronie in 1743, who identified the condition as the formation of fibrous plaques on the tunica albuginea of the penis. While historical understanding once attributed the condition to various lifestyle factors, modern medicine now recognizes Peyronie’s disease as a complex wound-healing disorder influenced by genetic predisposition and localized trauma.

Who first identified Peyronie’s disease?

Although the condition was noted by earlier physicians like Vesalius and Fallopius, it was François Gigot de la Peyronie, the surgeon to King Louis XV of France, who provided the definitive clinical characterization in 1743. In his famous report to the Royal Academy of Sciences in Paris, he described three patients presenting with penile curvature and palpable "plaques." For centuries, this eponymous name, Peyronie’s disease, has remained the standard medical term, marking the transition of the condition from a misunderstood anomaly to a recognized clinical diagnosis.

How has our understanding of Peyronie’s disease evolved?

For many years, Peyronie’s disease was surrounded by misconceptions, including the false belief that it was a sexually transmitted infection or a direct consequence of "moral failings." During the 19th and early 20th centuries, researchers began to move away from these stigmas, identifying it instead as a fibrotic condition. Today, our understanding of Peyronie’s disease centers on the "wound-healing hypothesis." This theory suggests that in genetically susceptible individuals, minor trauma to the penis triggers an abnormal inflammatory response, leading to the deposition of excess collagen rather than healthy tissue, resulting in the characteristic plaque and subsequent curvature.

What are the major milestones in treatment development?

The history of treating Peyronie’s disease is a journey from invasive, often ineffective surgeries to targeted, evidence-based therapies. Significant milestones include:

• Early 20th Century: The use of radiation therapy, which was later abandoned due to lack of efficacy and safety concerns.


• 1970s-1990s: The refinement of surgical techniques, such as the Nesbit procedure, which remains a gold standard for severe, stable curvature.


• 2013: The FDA approval of collagenase clostridium histolyticum (Xiaflex), the first non-surgical, injectable treatment specifically indicated for Peyronie’s disease.


• Modern Era: The adoption of traction therapy and vacuum erection devices as non-invasive methods to manage curvature and length loss.

How have technology and patient advocacy changed the landscape?

The rise of digital health platforms, including DiseaseMaps.org, has been transformative for those living with Peyronie’s disease. Historically, the condition was shrouded in silence due to the sensitive nature of sexual health. Patient advocacy groups have worked to normalize the conversation, helping men move past the shame that often accompanies the diagnosis. Furthermore, modern genetic research is currently investigating why some men develop significant plaques after minor injury while others do not, pointing toward specific markers in the TGF-beta signaling pathway.

Next steps

• Consult a board-certified urologist specializing in sexual medicine to discuss your specific curvature and symptoms.


• Document the progression of your Peyronie’s disease with photographs to help your physician assess the stability of the curvature.


• Connect with the community at DiseaseMaps.org to share experiences with others navigating the emotional and physical aspects of this condition.


• Avoid unproven "miracle cures" found online, as these can cause further injury to the penile tissue.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Peyronie disease overview.


• Orphanet: Rare disease database entry for fibrosing conditions of the penis.


• PubMed/NCBI: Historical reviews on the evolution of the surgical management of Peyronie’s disease.


• Sexual Medicine Society of North America (SMSNA): Patient education resources on Peyronie’s pathophysiology.